Mitochondrial donation, also called mitochondrial replacement therapy, is an IVF-based technique designed to reduce the chance that a mother passes serious mitochondrial DNA disease to a child. It combines nuclear DNA from the intended parents with mitochondria from a donor egg. Early human birth outcomes are limited, and laws differ by country.
Not sure where to start? Take the 3-min clinical quiz.
See if you qualify →What is mitochondrial donation?
Mitochondrial donation is a form of in vitro fertilization, or IVF, used in a narrow reproductive setting: helping some families lower the risk of passing serious mitochondrial DNA disease to a child. In UK guidance, it is described as an option only for people at very high risk of passing on a serious mitochondrial disease 1.
The short definition
In plain English, mitochondrial donation moves the intended parent’s nuclear genetic material into an egg or embryo that has donor mitochondria. The goal is to keep the intended parents’ nuclear DNA while reducing the child’s load of disease-causing mitochondrial DNA.
Why it is sometimes called mitochondrial replacement therapy
Mitochondrial replacement therapy, or MRT, is another name for mitochondrial donation. The term comes from the idea that mitochondria carrying pathogenic mitochondrial DNA variants are reduced or replaced with donated mitochondria that are expected to function normally 1.
Why the term three-parent baby can be misleading
You may see the phrase “three-parent baby.” It is catchy, but it can confuse more than it explains. Most of a child’s genetic instructions come from nuclear DNA from the egg and sperm; mitochondrial DNA is a much smaller genome that helps cells make energy 2.
That said, the donor’s mitochondria can be passed down the maternal line if the child is female, which is why regulators and ethicists treat mitochondrial donation as a germline technique. That means it can affect future generations, not just one pregnancy 3.
What are mitochondria, and who do you inherit them from?
Mitochondria are tiny structures inside cells that help turn food and oxygen into usable energy. In the clinical setting relevant to mitochondrial donation, mitochondrial DNA is usually inherited from the mother through the egg 2.
Mitochondria as cellular energy structures
Mitochondria are often called the cell’s energy centers. They are especially important in organs that use a lot of energy, such as the brain, heart, muscles, eyes, and nerves. That is why mitochondrial disorders can affect many body systems.
Mitochondrial DNA versus nuclear DNA
Nuclear DNA sits in the cell nucleus and contains most of the instructions that shape growth, body traits, and development. Mitochondrial DNA, or mtDNA, sits inside mitochondria and contains a much smaller set of genes that help mitochondria make energy 2.
For a deeper primer, our guides to mitochondrial DNA inheritance, mitochondrial mutations, and mitochondrial inheritance pedigrees explain why mtDNA patterns can look different from classic dominant or recessive inheritance.
Why mitochondrial DNA is usually inherited from the mother
Eggs contain many mitochondria. Sperm contribute nuclear DNA, but in typical human inheritance they do not pass on a meaningful mitochondrial DNA line. This is why women with pathogenic mtDNA variants can pass mitochondrial disease risk to their children 2.
Who might mitochondrial donation be intended to help?
Mitochondrial donation is intended for a small group of families with a high risk of severe mitochondrial DNA disease. It is not used for general fertility support, wellness, performance, or longevity.
Families at high risk of serious mitochondrial DNA disease
Examples of mitochondrial disorders include Leigh syndrome, MELAS, MERRF, and some forms of LHON. These conditions can be severe, and many have no curative treatment. Mitochondrial donation is meant to reduce inherited risk before pregnancy rather than treat a person who already has mitochondrial disease 1.
Heteroplasmy and homoplasmy in plain language
Heteroplasmy means a person has a mix of normal and disease-causing mitochondrial DNA. Homoplasmy means nearly all copies of mitochondrial DNA in a cell carry the same variant. This matters because preimplantation genetic testing may reduce risk for some heteroplasmic mtDNA disorders, while homoplasmic disorders can be harder to manage with embryo selection alone 4.
Why eligibility is narrow and requires specialist genetic counseling
Eligibility is narrow because the procedure involves IVF, egg or embryo manipulation, donor mitochondria, and future-generation questions. In the UK model, use is licensed and reviewed case by case by the Human Fertilisation and Embryology Authority, or HFEA 1.
How does mitochondrial donation work during IVF?
Mitochondrial donation happens in an IVF lab. The broad goal is to place the intended parent’s nuclear genetic material into an egg or embryo with donor mitochondria, then create or transfer an embryo under specialist care 1.
Step-by-step overview of IVF with mitochondrial donation
- 1A fertility and genetics team confirms the diagnosis, inheritance pattern, and reproductive goals.
- 2Eggs are collected from the intended mother and from a mitochondrial donor.
- 3The nuclear genetic material is moved using one of several lab methods.
- 4Intracytoplasmic sperm injection, or ICSI, may be used to fertilize the egg in the IVF lab.
- 5Embryos are monitored and may undergo genetic assessment depending on the case.
- 6An embryo may be transferred if it meets clinical, legal, and lab criteria.
Maternal spindle transfer
In maternal spindle transfer, or MST, the intended mother’s nuclear genetic material is removed from her egg before fertilization. It is then placed into a donor egg whose own nuclear genetic material has been removed, and the reconstructed egg is fertilized 1.
Pronuclear transfer
In pronuclear transfer, or PNT, both the intended mother’s egg and the donor egg are fertilized first. The intended parents’ pronuclei are then moved into the donor embryo after its pronuclei are removed 1.
What genetic material comes from each person
| Source | What is contributed | Plain-English meaning |
|---|---|---|
| Intended mother | Nuclear DNA | Most inherited instructions from the egg side |
| Intended father or sperm source | Nuclear DNA | Most inherited instructions from the sperm side |
| Mitochondrial donor | Mitochondrial DNA | Energy-related genes inside mitochondria |
Polar body transfer is another related method discussed in research, but the best-known clinical policy discussions usually focus on MST and PNT. No method removes all uncertainty, because small amounts of mitochondrial carryover may still occur.
How is mitochondrial donation different from donor eggs, donor embryos, adoption, or PGT?
Mitochondrial donation is one possible path among several reproductive options. The right comparison depends on the family’s diagnosis, values, legal access, fertility factors, and comfort with genetic parentage.
| Option | What it may help with | Genetic connection | Main limits |
|---|---|---|---|
| Mitochondrial donation | Reducing transmission of serious mtDNA disease | Child has intended parents’ nuclear DNA and donor mtDNA | Limited access, early evidence, germline and ethical concerns |
| Preimplantation genetic testing, or PGT | Selecting embryos with lower mutant mtDNA levels in some heteroplasmic cases | Child has intended parents’ nuclear DNA and mother’s mtDNA | May not help enough in homoplasmy or high-risk cases |
| Donor egg | Avoiding maternal mtDNA transmission | Child has donor egg nuclear DNA and donor mtDNA, plus sperm source DNA | Changes genetic parentage more substantially |
| Donor embryo | Avoiding transmission from both intended parents | Child is genetically related to embryo donors | No nuclear genetic link to intended parents |
| Adoption | Parenting without pregnancy or embryo creation | No genetic link to adoptive parents | Different legal, emotional, and practical process |
When preimplantation genetic testing may reduce risk
PGT can sometimes help when embryos have different levels of mutant mitochondrial DNA. In that setting, a fertility team may look for embryos with lower measured risk. Experts caution that PGT is not equally useful for every mtDNA condition, especially when the variant is homoplasmic 4.
When donor eggs or donor embryos change genetic parentage more substantially
Donor eggs and donor embryos can avoid passing the intended mother’s mitochondrial DNA, but they also change nuclear genetic parentage. For some families, that trade-off is acceptable. For others, mitochondrial donation is considered because it may preserve the intended mother’s nuclear genetic link while reducing mtDNA risk 4.
Why no option is right for every family
There is no single “best” option. A family may weigh medical risk, embryo handling, religious beliefs, genetic connection, cost, legal access, and the emotional burden of each path. This is why specialist genetic counseling is central.
What does the human evidence show so far?
Human evidence for mitochondrial donation is still early. Reported outcomes include a small number of births and early follow-up data, but this is not enough to prove lifelong safety or health across future generations.
Human clinical evidence: early birth and follow-up data
A registered 18-month outcome study of mitochondrial donation tracks early child outcomes after the procedure 5. Recent New England Journal of Medicine reports describe eight babies born after mitochondrial donation in the UK, with reduced risk markers reported in early follow-up 6.
That is encouraging for families facing serious mitochondrial disease risk, but it is still a small evidence base. Individual outcomes can vary, and early development does not answer every question about later childhood, adulthood, fertility, or future generations.
Observational and registry evidence in mitochondrial disease
Mitochondrial disease research often relies on observational cohorts, registries, and small clinical trials because many specific disorders are rare. A review of mitochondrial disorder trials describes an active but challenging clinical research field, with many studies focused on symptoms, biomarkers, and disease-specific outcomes rather than cure 7.
ClinicalTrials.gov also lists active and completed trials for conditions such as MELAS, MERRF, LHON, Pearson syndrome, and related disorders, but trial participation has eligibility rules, monitoring, risks, and rights 8.
Why early normal development does not prove lifelong safety
Mitochondrial DNA levels can vary by tissue and over time. A low mutant mtDNA level in blood is useful, but it may not fully predict levels in every organ for the rest of life. Experts therefore stress long-term follow-up after mitochondrial donation 6.
Why preclinical findings cannot be treated as human lifespan evidence
Animal, cell, biomarker, and mechanistic findings help scientists ask better questions. They do not prove that mitochondrial donation extends human lifespan. If you are reading longevity headlines, separate reproductive risk reduction from anti-aging claims; our guide to human longevity research explains this evidence gap in more detail.
Why is mitochondrial donation controversial?
Mitochondrial donation is controversial because it affects the germline, involves egg or embryo manipulation, and has limited long-term human outcome data. The debate is not only scientific; it is also ethical, legal, and social.
Germline inheritance and future generations
If a female child is born after mitochondrial donation, her donor mitochondrial DNA may be passed to her future children. That future-generation effect is why mitochondrial donation is often discussed under germline modification policy, even though it is not the same as editing nuclear genes 3.
Embryo handling and ethical concerns
Some methods, especially pronuclear transfer, involve creating and manipulating embryos in ways that may conflict with a person’s beliefs. Families may also have concerns about donor identity, consent, storage of embryos, and what happens to embryos that are not transferred.
Mitochondrial carryover and heteroplasmy concerns
Mitochondrial carryover means a small amount of the intended mother’s mitochondria may move with the nuclear DNA. If those mitochondria include pathogenic mtDNA, scientists watch for whether the level stays low or changes over time in different tissues 6.
Equity, access, cost, and regulation
Mitochondrial donation requires advanced IVF labs, donor eggs, genetics expertise, and long-term follow-up. That makes access uneven. Even where it is legal, families may face cost barriers, travel, waiting lists, and strict eligibility rules.
Where is mitochondrial donation legal or available?
Legal access depends on the country. The UK has a regulated model with case-by-case approval, while the United States restricts clinical use through federal policy that prevents FDA review of certain applications involving heritable genetic modification.
The UK model: licensed use and case-by-case approval
The UK became the first country to allow regulated mitochondrial donation treatment through a formal legal framework. The HFEA states that mitochondrial donation can be used only by people at very high risk of passing on serious mitochondrial disease, and clinics must be licensed 1.
Why availability varies by country
Countries differ in how they regulate embryo research, assisted reproduction, donor gametes, and germline techniques. Some allow tightly controlled clinical use, some allow research but not clinical use, and others restrict or prohibit the procedure.
Why mitochondrial replacement therapy is restricted in the United States
In the United States, Congress has used appropriations language to prevent the FDA from reviewing applications in which a human embryo is intentionally created or modified to include heritable genetic modification. This has kept clinical mitochondrial replacement therapy restricted in the US 9.
Questions to ask a fertility or genetics specialist
- What exact mitochondrial DNA variant is present, and is it heteroplasmic or homoplasmic?
- What is the estimated risk to a child without intervention?
- Could PGT meaningfully reduce risk in this specific case?
- Is mitochondrial donation legally available where we live or where we might seek care?
- What follow-up is expected for any child born after the procedure?
- What are the alternatives, including donor eggs, donor embryos, adoption, or no further pregnancy attempts?
Is mitochondrial donation a longevity treatment?
Mitochondrial donation is not a longevity treatment. It is a reproductive genetic technique studied for lowering the risk of serious inherited mitochondrial DNA disease, not for extending lifespan or slowing aging.
Why this is a reproductive genetic technique, not an anti-aging therapy
The clinical purpose of mitochondrial donation is to reduce disease transmission before pregnancy. Current human evidence concerns birth outcomes, early child health, and mutant mtDNA levels, not adult aging, lifespan, or healthspan 5.
How mitochondrial research differs from mitochondrial donation
Mitochondrial research is broad. It includes genetics, energy metabolism, disease trials, exercise biology, nutrition, and aging science. Mitochondrial donation is only one specialized reproductive technique within that larger field. For practical lifestyle evidence, see our guide on how to improve mitochondrial function.
How to read longevity headlines without overclaiming
A study in cells may show a mechanism. An animal study may suggest a possible pathway. A biomarker study may show a change in a lab measure. None of those proves longer human life. For mitochondrial donation, the honest answer is that the human evidence is about reproductive risk reduction, not longevity.
What should patients or families discuss with a specialist?
Families considering mitochondrial donation should speak with qualified fertility and genetics specialists. At Chia, we do not provide mitochondrial donation, IVF, embryo testing, donor egg services, fertility treatment, or genetic counseling.
Genetic testing and diagnosis
A specialist can confirm whether the condition is caused by mitochondrial DNA, nuclear DNA, or another cause. That distinction matters because mitochondrial donation targets mtDNA transmission risk, not every mitochondrial disorder.
Reproductive goals and alternatives
A care team can compare mitochondrial donation with PGT, donor eggs, donor embryos, adoption, and other paths. The decision is personal and may involve medical, ethical, cultural, financial, and legal factors.
Known and unknown risks
Known issues include the risks of IVF, ovarian stimulation, egg retrieval, embryo transfer, multiple visits, and emotional stress. Unknowns include long-term child outcomes and whether low mutant mtDNA levels remain stable across tissues and time 6.
Long-term follow-up for children born after the procedure
Long-term follow-up is central because the most important safety questions cannot be answered at birth. Families should ask what developmental, genetic, and medical monitoring is recommended through childhood and beyond.
FAQ
Usually, yes. The goal of mitochondrial donation is for the child to have nuclear DNA from the intended parents and mitochondrial DNA from a donor egg. The donor contributes mitochondrial DNA, not the main nuclear genome.
If a donor egg is used, the egg donor provides nuclear DNA and mitochondrial DNA from the egg. The child may still have DNA from the sperm source, but not nuclear DNA from the intended mother.
In the clinical setting relevant to mitochondrial disease, mitochondrial DNA is usually inherited from the mother through the egg.
No. Mitochondrial donation is intended to reduce the chance of passing certain mitochondrial DNA diseases to a child. It does not cure mitochondrial disease in a person who already has it.
US federal policy has prevented the FDA from reviewing certain applications involving embryos intentionally created or modified to include heritable genetic changes. As a result, clinical mitochondrial replacement therapy remains restricted in the United States.
No. Mitochondrial donation does not edit DNA letters with tools like CRISPR. It moves nuclear genetic material into an egg or embryo with donor mitochondria. It is still treated as a germline issue because mitochondrial DNA may be passed to future generations.
There is no human evidence that mitochondrial donation extends lifespan. Current human evidence concerns reproductive risk reduction for serious mitochondrial DNA disease, not longevity or anti-aging.
No. Chia does not offer mitochondrial donation, IVF, embryo testing, donor egg services, fertility treatment, or genetic counseling. Families considering these options should work with licensed fertility and genetics specialists.
References
- 1.Human Fertilisation and Embryology Authority. Mitochondrial donation treatment. HFEA, updated 2026.
- 2.Stewart JB, Chinnery PF. Extreme heterogeneity of human mitochondrial DNA from organelles to populations. Nature Reviews Genetics. 2021.
- 3.National Academies of Sciences, Engineering, and Medicine. Mitochondrial Replacement Techniques: Ethical, Social, and Policy Considerations. National Academies Press. 2016.
- 4.Poulton J, Chiaratti MR, Meirelles FV, Kennedy S, Wells D, Holt IJ. Transmission of mitochondrial DNA diseases and ways to prevent them. PLoS Genetics. 2010.
- 5.Newcastle upon Tyne Hospitals NHS Foundation Trust. Mitochondrial Donation: An 18 Month Outcome Study. ClinicalTrials.gov identifier NCT04113447. 2019.
- 6.New England Journal of Medicine. Reports on mitochondrial donation and preimplantation genetic testing for mitochondrial DNA disease. 2025.
- 7.Russell OM, Gorman GS, Lightowlers RN, Turnbull DM. Clinical trials in mitochondrial disorders, an update. Molecular Genetics and Metabolism. 2020.
- 8.National Library of Medicine. ClinicalTrials.gov search results for mitochondrial disease studies. 2026.
- 9.United States Congress. Consolidated Appropriations Act restrictions on FDA review of certain heritable genetic modification applications. 2024.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
Find what fits your body and your goals.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



